If the arrival of the first vaccines is announced in France for the beginning of 2021, many other candidate vaccines are still in the testing phase. Dijon University Hospital has been selected to carry out trials on two preventive treatments against Covid-19. He is now looking for volunteers.
Many laboratories have embarked on the race for the vaccine against Covid-19. Trials are increasing to ensure the effectiveness and safety of the solutions they offer. The Dijon University Hospital Center (CHU) organizes within its clinical investigation center a small part of the worldwide trials for two solutions developed by the Anglo-Swedish laboratory Astra Zeneca
“We are going to carry out two trials on preventive treatments against Covid. A vaccine trial of AstraZeneca which will probably start at the end of the year and a trial of what is called passive immunoprophylaxis still of AstraZeneca. These are two different approaches, which have the same objective of protecting the patient, specifies Maxime Luu, pharmacologist at the clinical investigation center. Either you are injected with the vaccine and you make your antibodies, or the antibodies are injected directly and provide immediate protection for the patient. “
video length: 01:33
–
Covid-19 vaccines: the CHU ready for trials
–
150 volunteers to find
To conduct these trials, the Dijon hospital is looking for 150 volunteers. In particular, people over 65 or suffering from chronic pathologies (diabetes, high blood pressure or obesity, for example). “The request that is made of us is to respond very quickly. That is to say to include a large number of patients very quickly since we are there in a response to a particular epidemic situation. So we need to have quick answers “, indicates Marc Bardou, medical coordinator of the clinical investigation center.
If you wish to participate in the trials, you can call 03 80 29 57 54 (Monday to Friday) or contact the clinical investigation center by email at [email protected]. It is also possible to spend by the national platform COVIREIVAC. The trials are to begin at the end of December 2020 or the beginning of January 2021. These are so-called phase 3 clinical trials, the last stage of testing before filing an application for marketing authorization for a product.
These trials are being carried out simultaneously in several countries and in around twenty hospitals that are part, such as Dijon University Hospital, of the vaccinology research network. The two treatments tested in Dijon are by injection. The method used is that of double-blind trials, one group of volunteers receives the vaccine, another group the placebo but neither the doctor nor the patient know who received what.
Engaged today in the fight against Covid-19, the clinical investigation center is participating, in parallel, in around fifty other trials in different therapeutic areas.
What are the 3 major steps in the manufacture of a vaccine?
–
–
Continue reading on these topics
–
–
